Citations

Clear

1320 citation(s) found for "Nguyen, Vi".

653 Phase I/II clinical trial for radiation and dendritic cell combination immunotherapy in patients with unresectable hepatocellular carcinoma and cholangiocarcinoma
Wu, Chen , Fonkoua, Lionel Aurelien Kankeu , Wang, Panwen , Hallemeier, Christopher L. , Atwell, Thomas D. , Bornschlegl, Svetlana, Martinez, Kodi, McCoy, Gabrielle, Regan, Kevin M., Shao, Zuoyi , Li, Ying , Hallemeier, Christopher Leigh , Tran, Nguyen, Wang, Junwen , Zhang, Henan , Dietz, Allan B. , Dong, Haidong , Park, Sean S. , Yi, Lin , Roberts, Lewis R.

Mayo Clinic

Regular and Young Investigator Award Abstracts | November 5, 2024 | Volume: No volume available | Issue: No issue available | Pages: A749-A750

10.1136/jitc-2024-sitc2024.0653 Get It

Dialysis Disparities: A Systematic Review of Homelessness and ESKD Care Challenges
Nguyen, P. , Acharya, Prakrati , Gonuguntla, Sadhana, Ahmad, Adeel , Thongprayoon, Charat , Gonuguntla, Sudhir, Zhang, Jennifer Y. , Suppadungsuk, Supawadee , Krisanapan, Pajaree , Miao, Jing , Cheungpasitporn, Wisit

Mayo Clinic

Journal of the American Society of Nephrology | October 28, 2024 | Volume: 35 | Issue: 10S | Pages: No page available

10.1681/asn.202485s21017 Get It

Predictors and Outcomes of Excellent Recanalization Versus Successful Recanalization After Thrombectomy in Proximal and Distal Medium Vessel Occlusion Strokes: A Multinational Study
Yedavalli, Vivek , Salim, Hamza , Adeeb, Nimer , Naamani, Kareem El, Henninger, Nils , Sundararajan, Sri Hari , Khalife, Jane , Ghozy, Sherief, Heit, Jeremy J. , Regenhardt, Robert W. , Puri, Ajit S., Dyzmann, Christian , Barreau, Xavier , Renieri, Leonardo, Filipe, João Pedro , Abdalkader, Mohamad , Marotta, Thomas R. , Spears, Julian , Biswas, Arundhati , Clarençon, Frédéric , Varela, Ricardo , Baker, Amanda , Altschul, David , Gonzalez, Nestor R. , Möhlenbruch, Markus , Costalat, Vincent , Stracke, Christian Paul , Shaikh, Hamza , Liebeskind, David S., Alexandre, Andrea , Tancredi, Illario , Faizy, Tobias D. , Kalsoum, Erwah , Lubicz, Boris , Patel, Aman B. , Guenego, Adrien , Investigators, the MAD MT, Liebeskind, David S. , Salim, Hamza , Liebeskind, David S. , Heit, Jeremy J , Altschul, David J , Gonzalez, Nestor R , Regenhardt, Robert W , Yedavalli, Vivek S , Henninger, Nils , Alexandre, Andrea M , Varela, Ricardo , Musmar, Basel , Naamani, Kareem El , Kühn, Anna Luisa , Ghozy, Sherief , Scarcia, Luca , Tan, Benjamin Yong‐Qiang , Cancelliere, Nicole M , Bernstock, Joshua D. , Rouchaud, Aymeric , Fiehler, Jens , Sheth, Sunil A , Essibayi, Muhammed Amir , Puri, Ajit S , Colasurdo, Marco , Renieri, Leonardo , Harker, Pablo , Radu, Răzvan Alexandru , Klein, Piers , Ota, Takahiro , Mowla, Ashkan , Jabbour, Pascal , Siegler, James E. , Nguyen, Thanh N. , Gory, Benjamin , Aziz‐Sultan, Mohammad Ali , Hecker, Constantin , Pedicelli, Alessandro , Mendes Pereira, Vitor , Dmytriw, Adam A. , Investigators, the MAD MT

Mayo Clinic

Stroke: Vascular and Interventional Neurology | October 26, 2024 | Volume: 4 | Issue: 6 | Pages: No page available

10.1161/svin.124.001421 | PMID 41583405 Get It

Background Acute ischemic stroke arising from medium vessel occlusions (MeVO) poses substantial challenges in treatment and management. This study aims to elucidate the outcomes and factors contributing to achieving excellent recanalization (modified Thrombolysis in Cerebral Infarction [mTICI] 2c–3) versus successful recanalization (mTICI 2b) in patients with MeVO stroke undergoing mechanical thrombectomy (MT). Methods We conducted a multinational study analyzing data from the MAD‐MT (Multicenter Analysis of Distal Medium Vessel Occlusions: Effect of Mechanical Thrombectomy) registry, encompassing 37 centers across North America, Asia, and Europe, collected between September 2017 and July 2023. The study included acute ischemic stroke patients with MeVO treated with MT, with or without intravenous thrombolysis, who achieved mTICI 2b–3 post‐MT. Results Among 1463 patients with successful recanalization (mTICI 2b–3), 523 achieved mTICI 2b recanalization, and 940 achieved mTICI 2c–3. Distal occlusions exhibited higher odds of excellent recanalization compared with proximal MeVO vessel occlusions (odds ratio, 1.58; 95% CI, 1.17–2.15; P = 0.003). Cardioembolic stroke pathogenesis was associated with a higher likelihood of excellent recanalization (1.67; 95% CI, 1.07–2.59; P = 0.018). Patients achieving mTICI 2c–3 recanalization demonstrated lower initial National Institutes of Health Stroke Scale scores, significant improvements in postprocedural National Institutes of Health Stroke Scale shift, and a higher percentage of favorable 90‐day outcomes compared with those with mTICI 2b. However, no significant difference in 90‐day mortality rates was observed. Conclusion This study underscores that among patients with MeVO stroke with successful recanalization (mTICI 2b–3) there is higher likelihood of achieving excellent recanalization (mTICI 2c–3) in distal occlusions and cardioembolic pathogenesis. mTICI 2c–3 scores post‐MT correlate with improved clinical outcomes compared with mTICI 2b, affirming the superiority of excellent recanalization over successful recanalization in patients with MeVO stroke. Further prospective studies and randomized controlled trials are warranted for validation.
Clinical Utility of a Digital Dermoscopy Image-Based Artificial Intelligence Device in the Diagnosis and Management of Skin Cancer by Dermatologists
Witkowski, Alexander , Burshtein, Joshua , Cockerell, Clay J. , Correa‐Selm, Lilia , Cotter, David G. , Ellis, Darrell L., Farberg, Aaron S. , Grant-Kels, Jane M, Greiling, Teri M. , Grichnik, James M. , Leachman, Sancy A. , Linfante, Anthony , Marghoob, Ashfaq A. , Paragh, György , Rabinovitz, Harold , Rigel, Darrell S. , Siegel, Daniel M. , Song, Eingun James , Swanson, David C. , Trask, David, Łudzik, Joanna , Correa, Lilia , Greiling, Teri M , Grichnik, James M , Leachman, Sancy A , Paragh, Gyorgy , Siegel, Daniel M , Song, Eingun James , Swanson, David, Ludzik, Joanna , Christopher, Michael, Ellis, Darrell L., Grant-Kels, Jane Margaret , Marks, Etan , Nguyen, Khoa, Ortega‐Loayza, Alex G. , Pellacani, Giovanni , Trask, David

Mayo Clinic

Cancers | October 25, 2024 | Volume: 16 | Issue: 21 | Pages: 3592

10.3390/cancers16213592 | PMID 39518033 Get It

Background: Patients with skin lesions suspicious for skin cancer or atypical melanocytic nevi of uncertain malignant potential often present to dermatologists, who may have variable dermoscopy triage clinical experience. Objective: To evaluate the clinical utility of a digital dermoscopy image-based artificial intelligence algorithm (DDI-AI device) on the diagnosis and management of skin cancers by dermatologists. Methods: Thirty-six United States board-certified dermatologists evaluated 50 clinical images and 50 digital dermoscopy images of the same skin lesions (25 malignant and 25 benign), first without and then with knowledge of the DDI-AI device output. Participants indicated whether they thought the lesion was likely benign (unremarkable) or malignant (suspicious). Results: The management sensitivity of dermatologists using the DDI-AI device was 91.1%, compared to 84.3% with DDI, and 70.0% with clinical images. The management specificity was 71.0%, compared to 68.4% and 64.9%, respectively. The diagnostic sensitivity of dermatologists using the DDI-AI device was 86.1%, compared to 78.8% with DDI, and 63.4% with clinical images. Diagnostic specificity using the DDI-AI device increased to 80.7%, compared to 75.9% and 73.6%, respectively. Conclusion: The use of the DDI-AI device may quickly, safely, and effectively improve dermoscopy performance, skin cancer diagnosis, and management when used by dermatologists, independent of training and experience.
S41 Predictive Yield of Targeted Endoscopic Ultrasound-Guided - Fine Needle Aspiration in Diagnosing Incidental Pancreatic Cysts
Hentz, Joseph G. , Anderson, Michelle A. , Faigel, Douglas O. , Pannala, Rahul , Jue, Terry L., Gurram, Priyatham , Mohammed, Adil Sarvar , Chen, Longwen , Fukami, Norio , Nguyen, Cuong Cao

Mayo Clinic

American Journal of Gastroenterology | October 24, 2024 | Volume: 119 | Issue: 10S | Pages: S31-S32

10.14309/01.ajg.0001028532.15843.fc Get It

S334 Systematic Literature Review and Meta-Analysis of Live Fecal Microbiota Therapeutics for Recurrent Clostridioides Difficile Infection
McCloskey, Conor , Reun, Corinne Le , Nguyen, Dianne, Crawford, Carl V. , Pardi, Darrell S. , Nair, Sunita, Vries, J. de, Wilcox, Mark H. , Vries, Jane De

Mayo Clinic

American Journal of Gastroenterology | October 24, 2024 | Volume: 119 | Issue: 10S | Pages: S237-S237

10.14309/01.ajg.0001030704.76662.2b Get It

CNS manifestations in acute and chronic graft-versus-host disease
Lambert, Nicolas , Forte, Florence, Monseur, Justine, Raus, Nicole, Shultz, Carl , Balaguer‐Roselló, Aitana , Gil‐Perotín, Sara , Brijs, Jan , Chauvet, Paul , Carré, Martin , Dulămea, Adriana Octaviana , Salmenniemi, Urpu , Nguyen, Stéphanie , Smallbone, Portia , González‐Vicent, Marta , Willems, Évelyne, Baron, Frédéric , Servais, Sophie , Béguin, Yves , Maquet, Pierre , Group, the CNS-GvHD Study, Lambert, Nicolas, Monseur, Justine, Raus, Nicole, Shultz, Carl, Brijs, Jan, Gavriilaki, Maria, Dulamea, Adriana Octaviana, Tănase, Alina , Salmenniemi, Urpu, Butera, Sara , Piekarska, Agnieszka , Davies, J. M., Labussière-Wallet, Hélène, D’Aveni, Maud , Willems, Evelyne, Gil-Perotín, Sara , Chalandon, Yves , Santoro, Jonathan D , Servais, Sophie , Lambert, Nicolas , Moussaoui, Majdouline El , Raus, Nicole, Polushin, Alexey Yu. , Michonneau, David , Hogan, William J. , Gavriilaki, Maria , Chalandon, Yves , Duminuco, Andrea , Ram, Ron , García‐Cadenas, Irene , Porto, Gaetana , Santoro, Jonathan D. , Group, the CNS-GvHD Study, Lambert, Nicolas, Monseur, Justine, Raus, Nicole, Skiba, Iaroslav B. , Shultz, Carl, Brijs, Jan, Gavriilaki, Maria, Sakellari, Ioanna , Dulamea, Adriana Octaviana, Chantepie, Sylvain , Salmenniemi, Urpu, Loschi, Michael L. , Martino, Massimo , Mensah‐Glanowska, Patrycja , Labussière-Wallet, Hélène, Hamadani, Mehdi , Willems, Evelyne

Mayo Clinic

Brain | October 23, 2024 | Volume: 148 | Issue: 4 | Pages: 1122-1133

10.1093/brain/awae340 | PMID 39442000 Get It

Abstract Despite the growing evidence supporting the existence of CNS involvement in acute and chronic graft-versus-host disease (CNS-GvHD), the characteristics and course of the disease are still largely unknown. In this multicentre retrospective study, we analysed the clinical, biological, radiological and histopathological characteristics, as well as the clinical course of 66 patients diagnosed with possible CNS-GvHD (pCNS-GvHD), selected by predetermined diagnostic criteria. Results were then contrasted depending on whether pCNS-GvHD onset occurred before or after Day 100 following allogeneic haematopoietic stem cell transplantation (allo-HSCT). The median time between allo-HSCT and pCNS-GvHD onset was 149 days (interquartile range25–75 48–321), and pCNS-GvHD onset occurred before Day 100 following transplantation in 44% of patients. The most frequent findings at presentation were cognitive impairment (41%), paresis (21%), altered consciousness (20%), sensory impairment (18%) and headache (15%). Clinical presentation did not significantly differ between patients with pCNS-GvHD occurring before or after Day 100 following transplantation. Brain MRI found abnormalities compatible with the clinical picture in 57% of patients, while CT detected abnormalities in only 7%. Seven patients had documented spinal cord MRI abnormalities, all of them with pCNS-GvHD occurring after Day 100 following transplantation. In the CSF, the white blood cell count was increased in 56% of the population (median 18 cells/μl). Histopathological analyses were performed on 12 specimens and were suggestive of pCNS-GvHD in 10. All compatible specimens showed parenchymal and perivascular infiltration by CD3+ and CD163+ cells. Immunosuppressive therapy was prescribed in 97% of patients, achieving complete clinical response in 27%, partial improvement in 47% and stable disease in 6%. Response to immunosuppressive therapy did not differ significantly between patients with pCNS-GvHD occurring before or after Day 100 following transplantation. Clinical relapse was observed in 31% of patients who initially responded to treatment. One-year overall survival following pCNS-GvHD onset was 41%. Onset before Day 100 following haematopoietic stem cell transplantation [hazard ratio with 95% confidence interval: 2.1 (1.0–4.5); P = 0.041] and altered consciousness at initial presentation [3.0 (1.3–6.7); P = 0.0077] were associated with a reduced 1-year overall survival probability. Among surviving patients, 61% had neurological sequelae. This study supports that immune-mediated CNS manifestations may occur following allo-HSCT. These can be associated with both acute and chronic GvHD and carry a grim prognosis. The clinical presentation as well as the radiological and biological findings appear variable.
Endovascular therapy versus medical management in isolated posterior cerebral artery acute ischemic stroke: A multinational multicenter propensity score-weighted study
Salim, Hamza , Pulli, Benjamin , Yedavalli, Vivek, Musmar, Basel , Adeeb, Nimer , Lakhani, Dhairya A. , Essibayi, Muhammed Amir , Naamani, Kareem El, Henninger, Nils , Sundararajan, Sri Hari , Khalife, Jane , Grewal, Inayat , Tan, Benjamin Yong‐Qiang , Regenhardt, Robert W. , Heit, Jeremy J , Rouchaud, Aymeric, Sheth, Sunil G. , Puri, Ajit S., Dyzmann, Christian , Barreau, Xavier, Filipe, João Pedro , Harker, Pablo, Abdalkader, Mohamad , Marotta, Thomas R. , Spears, Julian , Biswas, Arundhati , Clarençon, Frédéric , Varela, Ricardo , Baker, Amanda , Altschul, David , Gonzalez, Nestor R. , Möhlenbruch, Markus , Costalat, Vincent, Gory, Benjamin, Stracke, Christian Paul , Hecker, Constantin, Shaikh, Hamza, Liebeskind, David S. , Alexandre, Andrea , Tancredi, Illario, Faizy, Tobias D. , Kalsoum, Erwah , Lubicz, Boris , Patel, Aman B. , Guenego, Adrien, Investigators, for the MAD MT, Heit, Jeremy J. , Yedavalli, Vivek , Salim, Hamza , Lakhani, Dhairya , Scarcia, Luca , Regenhardt, Robert W , Fiehler, Jens , Alexandru Radu, Răzvan , Klein, Piers , Ota, Takahiro , Jabbour, Pascal , Nguyen, Thanh N , Gonzalez, Nestor R , Möhlenbruch, Markus A , Liebeskind, David S. , Alexandre, Andrea M , Faizy, Tobias D , Wintermark, Max , Heit, Jeremy J , Altschul, David J , Musmar, Basel , Essibayi, Muhammed Amir , Yedavalli, Vivek S , Henninger, Nils , Tan, Benjamin Yq , Pulli, Benjamin , Varela, Ricardo , Naamani, Kareem El , Kühn, Anna Luisa , Ghozy, Sherief , Cancelliere, Nicole M , Bernstock, Joshua D. , Rouchaud, Aymeric , Fiehler, Jens , Sheth, Sunil, Puri, Ajit S , Colasurdo, Marco , Barreau, Xavier , Renieri, Leonardo , Harker, Pablo , Radu, Răzvan Alexandru , Klein, Piers , Mowla, Ashkan , Jabbour, Pascal , Siegler, James E. , Nguyen, Thanh N. , Costalat, Vincent , Gory, Benjamin , Aziz‐Sultan, Mohammad Ali , Hecker, Constantin , Griessenauer, Christoph J. , Pedicelli, Alessandro , Tancredi, Illario , Mendes Pereira, Vitor , Guenego, Adrien , Dmytriw, Adam A. , Investigators, for the MAD MT

Mayo Clinic

European Stroke Journal | October 21, 2024 | Volume: 10 | Issue: 2 | Pages: 387-396

10.1177/23969873241291465 | PMID 39431327 Get It

Abstract Background: Despite the proven effectiveness of endovascular therapy (EVT) in acute ischemic strokes (AIS) involving anterior circulation large vessel occlusions, isolated posterior cerebral artery (PCA) occlusions (iPCAo) remain underexplored in clinical trials. This study investigates the comparative effectiveness and safety of EVT against medical management (MM) in patients with iPCAo. Methods: This multinational, multicenter propensity score-weighted study analyzed data from the Multicenter Analysis of primary Distal medium vessel occlusions: effect of Mechanical Thrombectomy (MAD-MT) registry, involving 37 centers across North America, Asia, and Europe. We included iPCAo patients treated with either EVT or MM. The primary outcome was the modified Rankin Scale (mRS) at 90 days, with secondary outcomes including functional independence, mortality, and safety profiles such as hemorrhagic complications. Results: A total of 177 patients were analyzed (88 MM and 89 EVT). EVT showed a statistically significant improvement in 90-day mRS scores (OR = 0.55, 95% CI = 0.30–1.00, p = 0.048), functional independence (OR = 2.52, 95% CI = 1.02–6.20, p = 0.045), and a reduction in 90-day mortality (OR = 0.12, 95% CI = 0.03–0.54, p = 0.006) compared to MM. Hemorrhagic complications were not significantly different between the groups. Conclusion: EVT for iPCAo is associated with better neurological outcomes and lower mortality compared to MM, without an increased risk of hemorrhagic complications. Nevertheless, these results should be interpreted with caution due to the study’s observational design. The findings are hypothesis-generating and highlight the need for future randomized controlled trials to confirm these observations and establish definitive treatment guidelines for this patient population.
EUS–guided therapies for primary and secondary prophylaxis in gastric varices—An updated systematic review and meta-analysis
Nguyen, Andrew K. L., Deliwala, Smit , Ramai, Daryl , Kassab, Lena L., Muthusamy, Arunkumar, Kamal, Faisal, Adler, Douglas G., Chandan, Saurabh , Nguyen, Andrew Khoi, Mohan, Babu P. , Facciorusso, Antonio , Bilal, Mohammad , Samanta, Jayanta

Mayo Clinic

Endoscopic Ultrasound | October 17, 2024 | Volume: 12 | Issue: 4 | Pages: 351-361

10.1097/eus.0000000000000017 | PMID 37795350 Get It

Abstract Background and Objectives Gastric varices (GVs) are associated with a higher risk of uncontrolled bleeding and death when compared with esophageal varices. While endoscopic glue injection therapy has been traditionally used for secondary prophylaxis in GV, data regarding primary prophylaxis continue to emerge. Recently, EUS–guided therapies have been used in GV bleeding. Methods We conducted a comprehensive search of several major databases from inception to June 2022. Our primary goals were to estimate the pooled rates of treatment efficacy, GV obliteration, GV recurrence, and rebleeding with EUS-guided therapy in primary and secondary prophylaxis. Overall adverse events and technical failures were assessed. Random-effects model was used for our meta-analysis, and heterogeneity was assessed using the I 2 % statistics. Results Eighteen studies with 604 patients were included. In primary prophylaxis, pooled rate of GV obliteration was 90.2% (confidence interval [CI], 81.1–95.2; I 2 = 0). With combination EUS–glue and coil therapy, the rate was 95.4% (CI, 86.7%–98.5%; I 2 = 0). Pooled rate of posttherapy GV bleeding was 4.9% (CI, 1.8%–12.4%; I 2 = 0). In secondary prophylaxis, pooled rate of treatment efficacy was 91.9% (CI, 86.8%–95.2%; I 2 = 12). With EUS-glue, EUS-coil, and combination EUS–glue and coil, the rates were 94.3% (CI, 88.9%–97.1%; I 2 = 0), 95.5% (CI, 80.3%–99.1%; I 2 = 0), and 88.7% (CI, 76%–95.1%; I 2 = 14), respectively. Pooled rate of GV obliteration was 83.6% (CI, 71.5%–91.2%; I 2 = 74). With EUS-glue, EUS-coil, and combination EUS–glue and coil, the rates were 84.6% (CI, 75.9%–90.6%; I 2 = 31), 92.3% (CI, 81.1%–97.1%; I 2 = 0), and 84.5% (CI, 50.8%–96.7%; I 2 = 75), respectively. Pooled rates of GV rebleeding and recurrence were 18.1% (CI, 13.1%–24.3%; I 2 = 16) and 20.6% (CI, 9.3%–39.5%; I 2 = 66), respectively. Conclusion Our analysis shows that EUS-guided therapy for GVs is technically feasible and clinically successful in both primary and secondary prophylaxis of GV.
Investigating the feasibility of 18F‐flortaucipir PET imaging in the antemortem diagnosis of primary age‐related tauopathy (PART): An observational imaging‐pathological study
Lavrova, Anna , Satoh, Ryota , Pham, Nha Trang Thu, Nguyen, Aivi T. , Jack, Clifford R. , Petersen, Ronald C. , Ross, Reichard R., Lowe, Val J. , Whitwell, Jennifer L. , Josephs, Keith A. , Lavrova, Anna , Jack, Clifford R , Nguyen, Aivi T , Satoh, Ryota , Ross, Reichard R., Dickson, Dennis W.

Mayo Clinic

Alzheimer's & Dementia | October 17, 2024 | Volume: 20 | Issue: 12 | Pages: 8605-8614

10.1002/alz.14301 | PMID 39417408 Get It

AbstractINTRODUCTIONPrimary age‐related tauopathy (PART) is characterized by neurofibrillary tangles and minimal β‐amyloid deposition, diagnosed postmortem. This study investigates 18F‐flortaucipir (FTP) PET imaging for antemortem PART diagnosis.METHODSWe analyzed FTP PET scans from 50 autopsy‐confirmed PART and 13 control subjects. Temporal lobe uptake was assessed both qualitatively and quantitatively. Demographic and clinicopathological characteristics and voxel‐level uptake using SPM12 were compared between FTP‐positive and FTP‐negative cases. Intra‐reader reproducibility was evaluated with Krippendorff's alpha.RESULTSMinimal/mild and moderate FTP uptake was seen in 32% of PART cases and 62% of controls, primarily in the left inferior temporal lobe. No demographic or clinicopathological differences were found between FTP‐positive and FTP‐negative cases. High intra‐reader reproducibility (α = 0.83) was noted.DISCUSSIONFTP PET imaging did not show a specific uptake pattern for PART diagnosis, indicating that in vivo PART identification using FTP PET is challenging. Similar uptake in controls suggests non‐specific uptake in PART.Highlights 18F‐flortaucipir (FTP) PET scans were analyzed for diagnosing PART antemortem. 32% of PART cases had minimal/mild FTP uptake in the left inferior temporal lobe. Similar to PART FTP uptake was found in 62% of control subjects. No specific uptake pattern was found, challenging in vivo PART diagnosis.